Email alerts

Subscribe to our mailing list

Testimonials

Since Tri-Solfen® was commercially launched, over 50 million lambs have been treated and over 60% of Australian wool growers are now using Tri-Solfen for their sheep. Here’s what some of them have to say…

‘We have used pain relief for two years now and seen real production gains. We are concerned for the welfare of our animals and will continue to use pain relief to ensure they get the best care.’

Clinton Wise– Wililoo Merino Stud, Woodanilling, W.A.

'It easy to see the difference pain relief makes. Before, lambs would walk away hunched up, even taking a couple of hours to walk back to the paddock. Now they run straight back to Mum and start suckling,” says Rod. “My wool is now sold under the Better Choices brand. I see this as a definite advantage. I think it will be an advantage in the long run, to both me and the industry as a whole.'

Rod Miller– Glenpaen Merino Stud, Horsham, Vic

'After being treated with pain relief my lambs were more content and less stressed. As farmers we are sincere in looking after the welfare of our animals and using pain relief demonstrates this.'

Richard Coole– Frankland, W.A.

'We have been using pain relief for the past three years. We’re impressed by reduced bleeding in the mulesing wound immediately after application. Lambs run straight back to find the ewe, which has dramatically reduced our mortality rates. Flock management, post lamb marking is easier due to the effect of pain relief and the scab healing faster.'

Ryan & Malcom O’Dea– Peepingee Merino Stud, Narrogin, W.A.

'Using pain relief eases the stress and allows lambs to mother up and move back to the paddock easier with faster weight gains.'

Kent Lummis– Waverley Downs, Gilgandra, NSW

Close

Patent Portfolio

Country Species Patent
Australia Sheep Granted
Australia Horses, Dogs, Lab animals Granted
Australia Cattle Granted
Australia Humans Granted
New
Zealand
Sheep,
Cattle
Granted
New
Zealand
Horses, Dogs, Lab animals Granted
EU Humans Granted
EU Pig, Sheep,
Cattle
Granted
USA Dogs, Horses, Lab animals Granted
USA Humans Granted
USA Pig, Sheep,
Cattle
Granted
Canada Horses, Dogs, Lab animals Granted
Canada Cattle,
Pig
Granted
Canada Humans Granted

Close

Advisory Board

Ian Page

Non-Executive Director

Ian is Chief Executive Officer of Dechra Pharmaceuticals, which has a 33% shareholder in Medical Ethics.
He joined National Veterinary Services, Dechra’s former services business in 1989 and joined the Board of Dechra in 1997. In October 2010, Ian was appointed as Non-Executive Chairman of Sanford DeLand Asset Management.

Dr Chris Roberts

Human Wound and Regulatory Advisor

Chris has over 20 years’ line management experience of heading clinical research teams. He was previously global head of Smith & Nephew clinical support and market development, where he managed global clinical Phase II and III programmes in the management of venous and pressure ulcers.

Dr Matthew Bayfield

Medical Specialist Scientific Director

Matthew is Head of Cardiothoracic Surgery at Strathfield Private Hospital and the Royal Prince Alfred Hospital. He is also a Fellow of the Royal Australasian College of Surgeons.

Professor Peter Windsor

Veterinarian Research Advisor

Peter is a registered specialist veterinary surgeon in New South Wales and an emeritus Professor at Sydney University. He holds a BVSc (Hons), PhD, DVSc and diploma from the European College of Small Ruminant Health Management.

Dr. Julian Braidwood

Global Regulatory Affairs Advisor

Julian has held leadership roles and managed international clinical projects with Grampian. He was previously Regulatory Affairs Manager at Novartis Animal Health. He is the Founder and Managing Director of Triveritas, where he is responsible for a team of 40 animal health specialists across the EU and the US.

Close

Calf Dehorning, disbudding registrations approved for Tri-Solfen

June 29, 2018

‘Dehorning and disbudding registrations approved for Tri-Solfen’ article written by Mark Phelps of Queensland Country Life.

ANIMAL pain relief product Tri-Solfen has now been registered for dehorning and disbudding in addition to castration for beef and dairy calves.

The new registration announced by the Australian Pesticides and Veterinary Medicines Authority on Thursday means the gel pain relief product is can be bought off the shelf from rural product resellers and used for all three husbandry practices.

Prior to the variation in the registration, livestock owners were only able to use Tri-Solfen was castration, unless it was prescribed by a vet for other purposes. Tri-Solfen has been registered for castration since 2016.

The product was originally developed for the sheep industry as a pain relief for mulesing. More than 80 per cent of Australia’s flock is understood to be treated with pain relief.

Tri-Solfen was developed by life science company Medical Ethics and is marketed by Bayer in Australia.

Medical Ethics managing director Allan Giffard said the variation in registration made the Tri-Solfen more accessible for the beef and dairy industries.

“The widespread adoption of pain relief has been remarkable,” Mr Giffard said.

“Based on the widespread uptake of Tri-Solfen, livestock producers have shown they are very willing to minimise pain and enhance wound healing that come with animal husbandry practices.”

Tri-Solfen is a pain relieving and wound healing formulation that has short term and long term analgesia, antiseptics, reduces blood loss and coats the wound. It costs between about a $1 and $1.50 to treat each animal. It is described as best suited to calves aged six to eight weeks and is designed to provide pain relief for 24 to 36 hours.

NEW APPROVALS: Tri-Solfen is now registered for dehorning and disbudding in addition to castration. Consolidated Pastoral Company’s Allawah stud manager Jason Purcell trialed the pain relief product during this year’s on-property branding of calves.

See this article directly on the Queensland Country Life website here.

Read more on Tri-Solfen here.